TELCOR Promotions - March 2025
Lincoln, NE – March 2026 TELCOR is proud to announce the promotion of Carl Dillow to Senior Analyst, RCM, Erik Spitz to Senior Analyst, RCM, and Dani...
The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.
Read ACLA’s full lawsuit.
Read the Final Judgment.
Lincoln, NE – March 2026 TELCOR is proud to announce the promotion of Carl Dillow to Senior Analyst, RCM, Erik Spitz to Senior Analyst, RCM, and Dani...
Despite recent legal challenges to the Trump administration’s sweeping tariffs, a Section 232 investigation is ongoing for imports of medical...
UnitedHealthcare (UHC) is now implementing new Routine Testing Management Policies for laboratory services, tests, and procedures in North Carolina,...